BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 12, 2010
View Archived Issues
Pregabalin therapy correlates with mild cognitive impairment
Read More
Apixaban more effective than enoxaparin in improving thromboprophylaxis after knee replacement
Read More
Long-term agalsidase beta treatment beneficial in Fabry's disease
Read More
Wyeth discloses novel mTOR and PI3K-alpha inhibitors
Read More
New semicarbazide-sensitive amine oxidase inhibitors disclosed by Hungarian researchers
Read More
Amgen discovers novel BACE 1 inhibitors
Read More
Potent and selective Chk1/Chk2 inhibitor V-158411 potentiates irinotecan antitumor activity in vivo
Read More
Potent and selective CSF-1-R inhibitor exhibits favorable pharmacokinetics and activity in vivo
Read More
Promising preclinical data presented on DGAT-1 inhibitor PF-04620110
Read More
ChemoCentryx presents new chemokine CCR1 receptor antagonists
Read More
Auspex Pharmaceuticals claims new deuterated pyrazole carboxamide coagulation factor Xa inhibitors
Read More
Achaogen completes series C financing to fund phase II ACHN-490 trial
Read More
Cubist doses first patient in phase II CB-183315 trial in Clostridium difficile-associated diarrhea
Read More
Rexahn submits protocol for phase II Serdaxin trial in Parkinson's disease to FDA
Read More
Xanodyne and Ferring enter copromotion agreement for Zipsor in U.S.
Read More
Celgene reports on phase I PDA-001 trial in Crohn's disease
Read More
Tragara completes enrollment in phase II trial of Capoxigem in NSCLC
Read More
FDA requests additional clinical data on ProStrakan's Rectogesic
Read More
FDA recommends additional trial of Cell Therapeutics' Pixuvri for NHL
Read More
Juventas begins phase I JVS-100 trial in patients with heart failure
Read More
Can-Fite BioPharma advances CF-1021 to phase I/II in liver cancer
Read More
Keryx begins enrollment in phase III KRX-0401 trial in colorectal cancer
Read More
Pharmasset advances PSI-938 to the clinic for hepatitis C
Read More
iBio grants rights to iBioLaunch platform for development of anthrax-plague combination vaccine
Read More
Cephalon acquires Mepha and Ception Therapeutics
Read More